Where Tech Meets Bio
Latest News
Trogenix Ltd has launched its Odysseus platform, leveraging Synthetic Super-Enhancer (SSE) technology to advance precision viral immunotherapy for aggressive cancers.
Read More
Novartis Expands Radiopharmaceutical Portfolio with $745M Deal with Ratio Therapeutics
Novartis has struck a licensing agreement with Boston-based biotech Ratio Therapeutics, securing global rights to a promising cancer candidate targeting somatostatin receptor 2 (SSTR2). The …
Read More
Medable Adds Generative AI to Simplify and Speed Up Clinical Trials
Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical trial workflows. The new feature, …
Read More
Latest News
40,000 NHS Healthcare Workers to Get AI Tool That Cuts Admin Time by 80%
Immunai and Teva Collaborate to Advance Clinical Trials in Oncology and Immunology
Enveda Advances AI-Discovered, Nature-Derived Drug ENV-294 to Phase 1 Trials
Genesis Therapeutics Collaborates with NVIDIA and Secures Additional NVentures Funding to Accelerate AI-Driven Drug Discovery
Recursion Unveils OpenPhenom-S/16: A Foundation Model for Microscopy Data
Schrödinger and Novartis Forge Partnership to Scale Computational Drug Discovery
Latest Insights
by Andrii Buvailo
85% of Healthcare Leaders Investing or Plan to Invest in Gen AI, According to the Largest Survey
Among many important helathcare tech topics discussed at the inagural HLTH Europe 2024 conference taking place on June 17-20 in Amsterdam, generative artificial intelligence (AI) …
Read More
by Andrii Buvailo, PhD
A Growing Race to Change Status Quo in the Lucrative NGS Market
Element Biosciences has raised over $277 million in a Series D funding round to further develop and commercialize its DNA sequencing and multi-omics technologies. The …
Read More
Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads
by Roman Kasianov
What will be the key trends in AI innovation in the Pharmaceutical Industry in 2025?
by Marina Hickson
Cautious Optimism in 2024 for Healthcare M&A
by Merlin Piscitelli
AI Is Key to Democratizing Drug Discovery
by Andrey Doronichev
Key Trends in Aging Research: Where Are We Now?
by Andrii Buvailo, PhD
Global Pharma R&D Investments Surpass $276 Billion Annually, Exceeding Previous Estimates
by Roman Kasianov
The Promise of Chatbots in Clinical Trials
by Illia Petrov
Even 10 Minutes Matter in Cancer Research
by Andrii Buvailo, PhD
From Our Partners
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
Lantern Pharma
AI Breaches the Barrier Towards Better CNS Drug Discovery
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Sponsored by
MEDSIR
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Partner Events
BIOCHINA 2025
Event Date: March 13, 2025 - March 15, 2025
Location: China (Suzhou International Expo Center)
Website: Link
Promo Code: biopharmatrend (valid till 2024-10-31)
Read more ›››
London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››
Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››
Case Studies
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Interviews
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
[Interview] A Company on the Cutting Edge of COVID-19 Vaccine Development
Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering
Most Read
Top 10 Companies Shaping the Brain-Computer Interface Landscape: Invasive vs Non-Invasive BCI Technology
AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry
The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between
12 Notable AI-powered Biotech Companies Founded in 2021